Cargando…

Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase

Introduction: The elderly are vulnerable to cardiovascular diseases and the incidence of atrial fibrillation (AF) and venous thromboembolism (VTE) increases significantly with age. Dabigatran is a commonly used new oral anticoagulant approved by the FDA for stroke prevention in patients with non-val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qingxia, Ding, Qian, Yan, Suying, Yue, Qun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727914/ https://www.ncbi.nlm.nih.gov/pubmed/35002709 http://dx.doi.org/10.3389/fphar.2021.769251

Ejemplares similares

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase
por: Zhang, Qingxia, et al.
Publicado: (2022)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016)

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
por: Dutta, Siddhartha, et al.
Publicado: (2022)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
por: Sultana, Janet, et al.
Publicado: (2020)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
por: Mhaidat, Nizar Mahmoud, et al.
Publicado: (2023)

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
por: Watson, Sarah, et al.
Publicado: (2022)

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
por: Barvaliya, Manish J., et al.
Publicado: (2023)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase(®)
por: Matlala, Mafora F., et al.
Publicado: (2023)

Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase
por: Star, Kristina, et al.
Publicado: (2014)

Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria
por: Yue, Qun-Ying, et al.
Publicado: (2022)

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase(®)
por: Vogel, Ulrich, et al.
Publicado: (2020)

A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization
por: Jeong, Han Eol, et al.
Publicado: (2022)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study
por: Watson, Sarah, et al.
Publicado: (2021)

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study
por: Frent, Ioana, et al.
Publicado: (2022)

Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019)

Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites
por: Juhlin, Kristina, et al.
Publicado: (2015)

Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
por: Park, Sunny, et al.
Publicado: (2021)

Short communication: Comments on hair disorders associated with dupilumab based on VigiBase
por: Park, Sunny, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System
por: Noseda, Roberta, et al.
Publicado: (2022)

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
por: Battini, Vera, et al.
Publicado: (2023)

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
por: Smadja, David M., et al.
Publicado: (2021)

Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
por: Fernandez, Silvia, et al.
Publicado: (2021)

Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019)

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
por: Rocca, Elena, et al.
Publicado: (2021)

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
por: Huruba, Madalina, et al.
Publicado: (2022)

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly
por: Sipos, Mariana, et al.
Publicado: (2021)

Adverse Drug Reaction Onsets in Uganda’s VigiBase(®): Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses
por: Kiguba, Ronald, et al.
Publicado: (2018)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016)

Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre
por: Star, Kristina, et al.
Publicado: (2019)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase
por: Noseda, Roberta, et al.
Publicado: (2021)

Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database
por: Pochet, Stéphanie, et al.
Publicado: (2022)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
por: HUANG, Sifu, et al.
Publicado: (2021)

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
por: Minnema, Lotte A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eeugk1j1q8gq913qgifhbs4tkj